• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Digirad plans executive shuffle, layoffs and restructuring for diagnostic imaging

Digirad plans executive shuffle, layoffs and restructuring for diagnostic imaging

March 7, 2013 By Arezu Sarvestani

Digirad logo

Diagnostics imaging devices maker Digirad Corp.(NSDQ:DRAD) announced some big changes for its primary business, as well as an executive shift and a number of layoffs.

The company hopes to "reduce costs and to focus on maximizing cash flow," and expects to complete restructuring efforts by the end of this year, according to a recent regulatory filing.

Those efforts will include an undisclosed number of layoffs and a new CEO. Current Digirad Corp. president & CEO Todd Clyde will vacate the corner office, fully effective July 1, 2013, to be replaced by Matthew Molchan, who has served as president for Digirad Imaging Solutions since January 2012. Clyde will stay on as CEO until the end of June to help smooth the transition while the company undergoes its restructuring, Clyde told investors during a conference call last week. Molchan has already gained the president title as of late last month.

During the conference call, Clyde explained the rationale behind the change in leadership.

"Keeping the current executive structure in place, after the restructuring, would result in a top-heavy organization and our principal goal is to create a lean company," he said. "In order to reduce costs further, we also plan on relocating the Digirad corporate headquarters to Atlanta, where Matt is based, from our current San Diego base, pending a complete examination of the cost of relocation."

The company is relocating its headquarters from Poway, Cali., to Atlanta, Ga..

Digirad’s diagnostic restructuring aims to reduce operating costs by $3-$4 million annually, with a focus on optimizing cash flow from the service and maintenance of its installed base of cameras, according to its latest financial report.

"We will continue to sell our solid-state cameras into the marketplace, we will simply be restructuring the imaging camera part of the diagnostics imaging business to no longer burn cash in this business," Clyde said. "We will thoughtfully pursue new opportunities to increase our DIS service, increase the asset utilization of that business and of course, with a total focus of increasing the cash flow by executing on financially disciplined acquisitions that align to our DIS business."

Filed Under: News Well Tagged With: Digirad Corp., Layoffs, Personnel Moves

More recent news

  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out
  • Former Masimo COO is joining BD to run Connected Care

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy